Loma Therapeutics ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About Loma Therapeutics ApS
Loma Therapeutics ApS (CVR number: 44226189) is a company from KØBENHAVN. The company recorded a gross profit of -2142.6 kDKK in 2024. The operating profit was -4297.7 kDKK, while net earnings were -4621.6 kDKK. The profitability of the company measured by Return on Assets (ROA) was -44 %, which can be considered poor and Return on Equity (ROE) was -90.4 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -47.3 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Loma Therapeutics ApS's liquidity measured by quick ratio was 15.3 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2024 | |
---|---|
Volume | |
Net sales | |
Gross profit | -2 142.61 |
EBIT | -4 297.71 |
Net earnings | -4 621.57 |
Shareholders equity total | -4 581.57 |
Balance sheet total (assets) | 5 112.92 |
Net debt | -5 041.30 |
Profitability | |
EBIT-% | |
ROA | -44.0 % |
ROE | -90.4 % |
ROI | |
Economic value added (EVA) | -4 297.71 |
Solvency | |
Equity ratio | -47.3 % |
Gearing | |
Relative net indebtedness % | |
Liquidity | |
Quick ratio | 15.3 |
Current ratio | 15.3 |
Cash and cash equivalents | 5 041.30 |
Capital use efficiency | |
Trade debtors turnover (days) | |
Net working capital % | |
Credit risk | |
Credit rating | C |
Variable visualization
Roles
Companies in the same industry
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.